Natasha B. Leighl, MD, MMSc, FRCP, FASCO Princess Margaret Cancer Center, Toronto 5Live #ASCO20
4:56
Key Insights on CCTG BR.34: A randomized trial of durvalumab and tremelimumab +/- platinum-based chemotherapy in patients with metastatic (Stage IV) squamous or nonsquamous non-small cell lung cancer (NSCLC).
Non Small Cell Lung Cancer
Natasha B. Leighl, MD, MMSc, FRCP, FASCO Princess Margaret Cancer Center, Toronto 5Live #ASCO20
Key Insights on CCTG BR.34: A randomized trial of durvalumab and tremelimumab +/- platinum-based chemotherapy in patients with metastatic (Stage IV) squamous or nonsquamous non-small cell lung cancer (NSCLC).
Non Small Cell Lung Cancer Similar Videos
Similar Videos
-
Uncommon and emerging targets for NSCLC_Fadlo Khuri, MD; #DDHO2021
2:39
-
Suresh Ramalingam, MD, FASCO; Winship Cancer Institute Emory University 5Live #ASCO20
5:27
Key insights on Nivolumab + ipilimumab versus platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer: Three-year update from CheckMate 227 Part 1.
-
Q&A and Panel Discussion
6:40
